Genzyme Foundation has awarded four grants aimed to improve the understanding, diagnosis and treatment of Multiple Sclerosis. Dr. Pablo Villoslada, from the IDIBAPS Neuroimmunology Program, was one of the awarded researchers in a ceremony held in Madrid on June 10. The project submitted by the team was entitled 'Brain Mapping of the decision-making processes (Neuroeconomics) in Multiple Sclerosis'. The rest of the awards were for the Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Clínico San Carlos (Madrid) and the Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Rocío.
Clínic Barcelona
Clínic Barcelona
June 14 2013